News

The patent claims are directed to formulations of Vinorelbine Bitartrate and provide protection for the company’s lead product candidate, ANX-530 (Vinorelbine injectable emulsion), or Exelbine. The notice of

VeriPsych is a molecular diagnostic tool designed to complement the healthcare provider’s clinical impression. VeriPsych, based on the simultaneous measurement of 51 different protein and hormone biomarkers with

Verisens PSA is an in-vitro diagnostic assay for the high-sensitivity detection and quantification of prostate specific antigen (PSA), developed in collaboration with the International Institute for Nanotechnology at

MP4 molecule is an investigational biopharmaceutical product designed to enhance the perfusion and oxygenation of oxygen-deprived tissues and provide targeted oxygen delivery to the capillaries in severely injured

The patent entitled ‘Methods for Treatment with Bucindolol Based on Genetic Targeting,’ provides protection for this approach to treat patients with heart failure in France, Germany, Netherlands, Switzerland/Liechtenstein,

Clariant claims that the new Mevopur brand acknowledges the pharmaceutical and medical industry’s need for material consistency, reliability and change-control and can help brand owners and manufacturers minimise

SAFC’s 50,000 sqft cGMP fermentation expansion, which is expected to begin production in October 2010, will focus on niche fermentation of APIs and bulk drugs, producing secondary metabolites

As per the terms of the agreement, NovaBiotics is expected to expand its product portfolio by working with Isogenica on two research projects, one concerning peptide selection and

StemedicaAnC is expected to manufacture stem cells developed by Stemedica for the treatment of ischemic stroke and other degenerative disorders. Stemedica president and chief medical officer Nikolai Tankovich